Infection Rates in Device Replacement Procedures: Key Insights from the REPLACE Registry

Strategic Insights -

The REPLACE Registry, a large prospective study, has provided significant insights into the factors influencing infection rates in device replacement procedures. Analysis of 1,031 patients undergoing elective replacement of their implanted cardiac rhythm management (CRM) device revealed two key factors contributing to infection rates: preoperative skin preparation and post-operative antibiotic use. The study's findings suggest that skin preparation with povidone-iodine increases infection rates, whereas chlorhexidine-containing compounds show a lower rate. Additionally, the incidence of infection among patients receiving no postoperative antibiotics is lower compared to those receiving parenteral antibiotics.

Key Takeaways:

  • The REPLACE Registry analyzed 1,031 replacement procedures with representative devices from five CRM manufacturers, highlighting the significance of this study in understanding infection rates in device replacement procedures.
  • Preoperative skin preparation with povidone-iodine was associated with a significantly higher infection rate (2.1%) compared to chlorhexidine-containing compounds (0.2%), with a p-value of 0.013.
  • Post-operative antibiotic use, specifically parenteral antibiotics, showed no benefit in reducing infection rates, whereas patients receiving no postoperative antibiotics had a lower incidence of infection (0.5%).
  • Jenafrade (Parenteral antibiotics) administration was associated with an increased rate of infection (2.3%).
  • Daniel Uslan, MD, Assistant Clinical Professor at UCLA, noted that postoperative IV antibiotics do not seem to decrease the risk of infection.
  • Jeanne Poole, MD, National Principal Investigator for the REPLACE Registry, highlighted the variety of antibiotic prophylaxis measures used by site investigators.
  • The REPLACE Registry is the first large, prospective study to evaluate the factors influencing infection rates in device replacement procedures.

Statistics:

  • 1,031 patients underwent elective replacement of their implanted CRM device as part of the REPLACE Registry
  • Infection rates varied significantly between skin preparation techniques: povidone-iodine (2.1%) vs. chlorhexidine-containing compounds (0.2%)
  • Post-operative antibiotic use showed no benefit in reducing infection rates: 2.3% for patients receiving parenteral antibiotics vs. 0.5% for those receiving no postoperative antibiotics
  • More than 4,500 employees and represented in over 100 countries, BIOTRONIK, Inc. is one of the world's leading cardiovascular medical device companies.

Sources:

  • BIOTRONIK, Inc. press release
  • Infectious Diseases Society of America Scientific Sessions
  • NewsRx.com (Biotech Week editors)
  • UCLA press release
  • REPLACE Registry study published in [insert journal name, publication date and issue, if available]